These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17975143)
41. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Wei YS; Lan Y; Luo B; Lu D; Nong HB Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899 [TBL] [Abstract][Full Text] [Related]
42. Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. Pai PC; Tseng CK; Chuang CC; Wei KC; Hao SP; Hsueh C; Chang KP; Tsang NM Head Neck; 2007 Feb; 29(2):109-19. PubMed ID: 17103409 [TBL] [Abstract][Full Text] [Related]
43. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557 [TBL] [Abstract][Full Text] [Related]
44. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx. Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751 [TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278 [TBL] [Abstract][Full Text] [Related]
46. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients. Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM Clin Cancer Res; 2008 Jul; 14(13):4141-5. PubMed ID: 18593992 [TBL] [Abstract][Full Text] [Related]
47. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891 [TBL] [Abstract][Full Text] [Related]
48. Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Xiong W; Zeng ZY; Li XL; Li WF; Li J; He L; Li GY Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):512-5. PubMed ID: 12098778 [TBL] [Abstract][Full Text] [Related]
49. Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Jemaa R; Rojbani H; Kallel A; Ben Ali S; Feki M; Chabrak S; Elasmi M; Taieb SH; Sanhaji H; Souheil O; Mechmeche R; Kaabachi N Clin Chim Acta; 2008 Apr; 390(1-2):122-5. PubMed ID: 18230355 [TBL] [Abstract][Full Text] [Related]
50. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020 [TBL] [Abstract][Full Text] [Related]
51. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Farhat K; Hassen E; Gabbouj S; Bouaouina N; Chouchane L Int J Immunogenet; 2008 Jun; 35(3):197-205. PubMed ID: 18312596 [TBL] [Abstract][Full Text] [Related]
52. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218 [TBL] [Abstract][Full Text] [Related]
53. Galectin-1 overexpression in nasopharyngeal carcinoma: effect on survival. Chang SL; Li CF; Lin C; Lin YS Acta Otolaryngol; 2014 May; 134(5):536-42. PubMed ID: 24646142 [TBL] [Abstract][Full Text] [Related]
54. [Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma]. Zhang S; Yang JH; Cai PC Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3131-4. PubMed ID: 19159596 [TBL] [Abstract][Full Text] [Related]
55. Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension. Ben Chaaben A; Busson M; Douik H; Boukouaci W; Mamoghli T; Chaouch L; Harzallah L; Dorra S; Fortier C; Ghanem A; Charron D; Krishnamoorthy R; Guemira F; Tamouza R Tissue Antigens; 2011 Aug; 78(2):148-51. PubMed ID: 21623733 [TBL] [Abstract][Full Text] [Related]
56. [Expression of desmoglein 3 in nasopharyngeal carcinoma: research of 22 cases]. Liu ZQ; Tian YQ; Ma FR; Zhu L; Hu YF Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2541-3. PubMed ID: 18067828 [TBL] [Abstract][Full Text] [Related]
57. [Expressions of P16 and nm23-H1 in nasopharyngeal cacinoma and their clinical significance]. Chen SY; Wang XQ; Li XM; Chen YX; Wu CQ Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):342-4, 348. PubMed ID: 15772009 [TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Gao LB; Liang WB; Xue H; Rao L; Pan XM; Lv ML; Bai P; Fang WL; Liu J; Liao M; Zhang L Clin Chim Acta; 2009 Nov; 409(1-2):132-5. PubMed ID: 19758567 [TBL] [Abstract][Full Text] [Related]
59. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients. Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971 [TBL] [Abstract][Full Text] [Related]
60. Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients. Fang FM; Chien CY; Li CF; Shiu WY; Chen CH; Huang HY Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):202-7. PubMed ID: 18538504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]